Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs

Por Aloysius, Mark M, Mc Kechnie, Alastair J, Robins, Richard A, Verma, Chandan, Eremin, Jennifer M, Farzaneh, Farzin, Habib, Nagy A, Bhalla, Joti, Hardwick, Nicola R, Satthaporn, Sukchai, Sreenivasan, Thiagarajan, El-Sheemy, Mohammed, Eremin, Oleg
Publicado em 2009

p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8(+) T cell responses

Por Hardwick, Nicola R, Carrol, Mary, Kaltcheva, Teodora, Qian, Dajun, Lim, Dean, Leong, Lucille, Chu, Peiguo, Kim, Joseph, Chao, Joseph, Fakih, Marwan, Yen, Yun, Espenschied, Jonathan, Ellenhorn, Joshua D I, Diamond, Don J, Chung, Vincent
Publicado em 2014

p53-reactive T cells are associated with clinical benefit in patients with platinum-resistant epithelial ovarian cancer after treatment with a p53 vaccine and gemcitabine chemother...

Por Hardwick, Nicola R, Frankel, Paul, Ruel, Christopher, Kilpatrick, Julie, Tsai, Weimin, Kos, Ferdynand, Kaltcheva, Teodora, Leong, Lucille, Morgan, Robert, Chung, Vincent, Tinsley, Raechelle, Eng, Melissa, Wilczynski, Sharon, Ellenhorn, Joshua D I, Diamond, Don J, Cristea, Mihaela
Publicado no Clin Cancer Res (2018)